Finding cases of dementia and mild cognitive impairment in Pavia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to tackle the global public health challenge of dementia by focusing on early detection and comprehensive care. It evaluates the effectiveness of case-finding strategies through the 'Ricor-Dare' project, which seeks to create an integrated network for identifying new cases of dementia or Mild Cognitive Impairment (MCI) and providing necessary support to patients and caregivers. Additionally, it involves establishing a new Center for Cognitive Disorders and Dementia in an area lacking such services, thereby enhancing the healthcare response to cognitive decline.

Why it matters

Who can join: the full rules

For the Primary Outcome the inclusion criteria are:

* Age 50 or older
* Assessment conducted using GPcog/ACE-III depending on the setting
* No prior diagnosis of cognitive decline
* Ability to understand the study objectives and sign an informed consent

For the Primary Outcome the exclusion criteria are:

* Age under 50
* Presence of a diagnosis of cognitive decline
* Limited knowledge of the Italian language

For the secondary outcome the inclusion criteria are:

Patient:

* All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina;
* Ability to understand the aims of the study and to sign an informed consent

Caregiver:

* Age equal to or greater than 18 years
* Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD;
* Acceptance of informed consent and voluntary participation in the study.

Healthcare professionals:

* All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training;
* Acceptance of informed consent and voluntary participation in the study.

Fo the Secondary Outcome the exclusion criteria are:

Patient:

\- Inability to understand the aims of the study and to sign an informed consent

Caregiver:

* Age under 18
* Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee;
* Caregivers with limited knowledge of the Italian language.

Where it's running

• IRCCS National Neurological Institute "C. Mondino" Foundation
  Pavia, Pavia, Italy Recruiting

Study contacts

• Study coordinator: Nicola Allegri, PhD
• Email: nicola.allegri@mondino.it
• Phone: 0039 0381692413

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Gut and Oral Microbiome and Cognitive Health in Aging

  This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.

  Recruiting University of South Florida · Tampa, Florida · NCT07799402

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• AI-supported sleep program for people with mild cognitive impairment or dementia

  A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.

  Recruiting The Hong Kong Polytechnic University · Kowloon, Hung Hom · NCT07784946

• Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease

  A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07717567

• Music for Pain and Dementia: Group Drumming for people with early dementia and their caregivers

  This study tests whether group drumming can reduce pain and change brain activity in people with mild dementia or mild cognitive impairment and in their caregivers.

  Recruiting Yale University · New Haven, Connecticut · NCT07602283

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.